Humoral and cellular immune correlates of protection against bubonic plague by a live Yersinia pseudotuberculosis vaccine
Abstract
No abstract availableKeywords
Funding Information
- ANR Emergence (ANR-12-EMMA-0011-01)
- Institut Pasteur Accelerating Preclinical Candidates – GPF – Vaccinology 2015 (GPFVacc2-08)
This publication has 43 references indexed in Scilit:
- Vaccination recommendations for the adult immunosuppressed patient: A systematic review and comprehensive field synopsisJournal of Autoimmunity, 2017
- Assessment of Live Plague Vaccine Candidates2016
- A single component two-valent LcrV-F1 vaccine protects non-human primates against pneumonic plagueVaccine, 2009
- Antibodies and cytokines independently protect against pneumonic plagueVaccine, 2008
- Toll-Like Receptor 6 Drives Differentiation of Tolerogenic Dendritic Cells and Contributes to LcrV-Mediated Plague PathogenesisCell Host & Microbe, 2008
- Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plagueVaccine, 2008
- Antibody profiling in plague patients by protein microarrayMicrobes and Infection, 2008
- Cell-mediated immunity and the challenges for vaccine developmentTrends in Microbiology, 2006
- A Salmonella enterica serovar Typhi vaccine expressing Yersinia pestis F1 antigen on its surface provides protection against plague in miceVaccine, 2004
- Plague as a Biological WeaponJAMA, 2000